Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Critical Care Medicine
|
May 1, 1993
Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade
B P Giroir
Critical Care Medicine
|
September 28, 2000
Meningococcemia as a model for testing the hypothesis of antisepsis therapies
B P Giroir
Circulatory Shock
|
March 1, 1992
Effect of amrinone on tumor necrosis factor production in endotoxic shock
B P Giroir, B Beutler
New Horizons (Baltimore, Md.)
|
May 1, 1995
Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors
G Williams, B P Giroir
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1992
Constitutive synthesis of tumor necrosis factor in the thymus
B P Giroir, T Brown, B Beutler
Critical Care Medicine
|
July 11, 2001
Bactericidal/permeability-increasing protein--lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia
B P Giroir, P J Scannon, M Levin
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1981
The fine specificity of immune suppression to individual nucleosides
E C Raps, B P Giroir, Y Borel
Virology
|
July 15, 1985
Cell lines derived from avian lymphomas exhibit two distinct phenotypes
T W Baba, B P Giroir, E H Humphries
Journal of Molecular and Cellular Cardiology
|
July 11, 2001
Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure
S B Haudek, D D Bryant, B P Giroir
European Cytokine Network
|
November 1, 1992
The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors
B P Giroir, K Peppel, M Silva, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Critical Care Medicine
|
May 1, 1993
Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade
B P Giroir
Critical Care Medicine
|
September 28, 2000
Meningococcemia as a model for testing the hypothesis of antisepsis therapies
B P Giroir
Circulatory Shock
|
March 1, 1992
Effect of amrinone on tumor necrosis factor production in endotoxic shock
B P Giroir, B Beutler
New Horizons (Baltimore, Md.)
|
May 1, 1995
Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors
G Williams, B P Giroir
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1992
Constitutive synthesis of tumor necrosis factor in the thymus
B P Giroir, T Brown, B Beutler
Critical Care Medicine
|
July 11, 2001
Bactericidal/permeability-increasing protein--lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia
B P Giroir, P J Scannon, M Levin
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1981
The fine specificity of immune suppression to individual nucleosides
E C Raps, B P Giroir, Y Borel
Virology
|
July 15, 1985
Cell lines derived from avian lymphomas exhibit two distinct phenotypes
T W Baba, B P Giroir, E H Humphries
Journal of Molecular and Cellular Cardiology
|
July 11, 2001
Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure
S B Haudek, D D Bryant, B P Giroir
European Cytokine Network
|
November 1, 1992
The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors
B P Giroir, K Peppel, M Silva, et al.
Page
of 3